首页|Sturge-Weber syndrome:an update for the pediatrician
Sturge-Weber syndrome:an update for the pediatrician
扫码查看
点击上方二维码区域,可以放大扫码查看
原文链接
NETL
NSTL
万方数据
Background Sturge-Weber syndrome(SWS)is a rare congenital neurocutaneous disorder characterized by the simultane-ous presence of both cutaneous and extracutaneous capillary malformations.SWS usually presents as a facial port-wine birthmark,with a varying presence of leptomeningeal capillary malformations and ocular vascular abnormalities.The latter may lead to significant neurological and ocular morbidity such as epilepsy and glaucoma.SWS is most often caused by a somatic mutation involving the G protein subunit alpha Q or G protein subunit alpha 11 gene causing various alterations in downstream signaling pathways.We specifically conducted a comprehensive review focusing on the current knowledge of clinical practices,the latest pathophysiological insights,and the potential novel therapeutic avenues they provide.Data sources A narrative,non-systematic review of the literature was conducted,combining expert opinion with a balanced review of the available literature.A search of PubMed,Google Scholar and Embase was conducted,using keywords"Sturge-Weber Syndrome"OR"SWS","Capillary malformations","G protein subunit alpha 11"OR"G protein subunit alpha Q".Results One of the hallmark features of SWS is the presence of a port-wine birthmark at birth,and forehead involvement is most indicative for SWS.The most common ocular manifestations of SWS are glaucoma and choroidal hemangioma.Glau-coma presents in either in infancy(0-3 years of age)or later in life.Neurological complications are common in SWS,occurring in about 70%-80%of patients,with seizures being the most common one.SWS significantly impacts the quality of life for patients and their families,and requires a multidisciplinary approach for diagnosis and treatment.Currently,no disease-modifying therapies exist,and treatment is mostly focused on symptoms or complications as they arise.Conclusions SWS remains a complex and heterogeneous disorder.Further research is needed to optimize diagnostic and therapeutic strategies,and to translate insights from molecular pathogenesis to clinical practice.